Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - tetanus toxoid diphtheria toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin polio virus type 1 inactivated polio virus type 2 inactivated polio virus type 3 inactivated adsorbed fimbriae types 2 + 3 - suspension for injection - %v/v

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tetanus toxoid, quantity: 20 lfu/ml; poliovirus, quantity: 80 agu/ml; pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; poliovirus, quantity: 16 agu/ml; pertactin, quantity: 16 microgram/ml; poliovirus, quantity: 64 agu/ml; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 50 lfu/ml - injection, solution - excipient ingredients: aluminium hydroxide hydrate; water for injections; neomycin sulfate; polymyxin b sulfate; sodium chloride; glucose monohydrate; polysorbate 80; ascorbic acid; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicoti - 1. infanrix-ipv is indicated for use in a three dose primary schedule for immunisation of infants from 6 weeks of age and over, against diphtheria, tetanus, pertussis and poliomyelitis. infanrix-ipv is also indicated as a single booster dose for children, up to and including 6 years of age, who have previously been immunised against diphthereia, tetanus, pertussis and polio.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - diphtheria toxoid; tetanus toxoid; pertussis toxoid (pt); pertactin (69 kda outer membrane protein-69k); inactivated polio virus type 3; inactivated polio virus type 2; inactivated polio virus type 1; filamentous haemagglutinin (fha) -

Ireland - English - HPRA (Health Products Regulatory Authority)

aj vaccines a/s - diphtheria toxoid, purified; tetanus toxoid, purified; pertussis toxoid, purified - suspension for injection in pre-filled syringe - < 2 international unit(s) - pertussis vaccines; pertussis, purified antigen, combinations with toxoids

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - diphtheria-tetanus toxoids and acellular pertussis vaccine, adsorbed - 0.5 ml suspension for injection (im) - 2pe (see reverse for formulation) - formulation: each dose (0.5 ml) contains: diphtheria toxoid -2.5lf tetanus toxoid-5.0 lf pertussis toxoid-8 mcg filamentous hemagglutinin (fha)-8 mcg pertactin (prn or 69 kda omp)-2.5 mcg

Philippines - English - FDA (Food And Drug Administration)

 ; importer:  ; distributor:   - tetanus and diphtheria toxoids adsorbed combined with component acellular pertussis vaccine - solution for injection (im) - formulation: each dose (0.5 ml) contains: diphtheria toxoid adsorbed-2 lf tetanus toxoid adsorbed- 5lf component acellular pertussis pertussis toxoid adsorbed-2.5 mcg filamentous haemagglutinin adsorbed-5 mcg fimbriae types 2 and 2 adsorbed-5 mcg pertactin adsorbed-5 mcg

Canada - English - Health Canada

connaught laboratories ltd. - diphtheria toxoid - liquid - 0.2lf - diphtheria toxoid 0.2lf - toxoids

Canada - English - Health Canada

aventis pasteur limited - diphtheria toxoid - liquid - 50lf - diphtheria toxoid 50lf - toxoids

Canada - English - Health Canada

aventis pasteur limited - diphtheria toxoid - liquid - 4lf - diphtheria toxoid 4lf - toxoids

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; pertactin, quantity: 16 microgram/ml; tetanus toxoid, quantity: 80 iu/ml; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 60 iu/ml - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; sodium chloride - infanrix is indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole-cell) vaccine. indications as of 8th january 1997 - infanrix (dtpa) is indicated for active primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. infanrix (dtpa) is also indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria,tetanus and pertussis (whole-cell or acellular) vaccine.